Skip to main content

Compton Capital Management Inc

SEC CIK
0001080071
Latest filing
Aug 9, 2023

ABT holding history

Abbott Laboratories in every 13F filed by Compton Capital Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2023 holdings

Shares (Q2 2023)
2,056
Value
$224.1K
% of portfolio
5.2%
Quarters held
10
Since Q1 2021
Holdings of ABT by Compton Capital Management Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20232,056$224.1K5.2%−6,535−76.1%ReducedHolders
Q1 20238,591$869.9K1.9%−15,550−64.4%ReducedHolders
Q4 202224,141$2.65M1.9%−2,632−9.8%ReducedHolders
Q3 202226,773$2.59M1.7%−734−2.7%ReducedHolders
Q2 202227,507$2.99M1.6%−5,682−17.1%ReducedHolders
Q1 202233,189$3.93M1.1%−160−0.5%ReducedHolders
Q4 202133,349$4.69M1.2%00.0%UnchangedHolders
Q3 202133,349$3.94M1.2%−187−0.6%ReducedHolders
Q2 202133,536$3.89M1.1%+250+0.8%AddedHolders
Q1 202133,286$3.99M1.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.